欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DK/H/2871/001
药品名称
Picoprep
活性成分
citric acid 12.0 g
Magnesium oxide 3.5 g
Sodium picosulfate 10.0 mg
剂型
Powder for oral solution
上市许可持有人
Ferring Lægemidler A/S Kay Fiskers Plads 11 2300 København S
参考成员国 - 产品名称
Denmark (DK)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
PL 03194/0014 - 0080
Germany (DE)
PICOPREP Pulver zur Herstellung einer Lösung zum Einnehmen
Belgium (BE)
Netherlands (NL)
picoprep
Luxembourg (LU)
Iceland (IS)
Austria (AT)
Picoprep Pulver zur Herstellung einer Lösung zum Einnehmen
France (FR)
Spain (ES)
Portugal (PT)
Italy (IT)
Greece (GR)
Sweden (SE)
Picoprep
Norway (NO)
Finland (FI)
Latvia (LV)
Lithuania (LT)
PICOPREP milteliai geriamajai suspensijai
Estonia (EE)
Hungary (HU)
PICOPREP por belsőleges oldathoz
Bulgaria (BG)
PICOPREP
Cyprus (CY)
PICOPREP PWD FOR ORAL SOLUTION
Czechia (CZ)
PICOPREP PRÁŠEK PRO PŘÍPRAVU PERORÁLNÍHO ROZTOKU
Romania (RO)
Picoprep pulbere pentru solutie orala
Slovakia (SK)
PICOPREP
许可日期
2010/05/27
最近更新日期
2024/10/21
药物ATC编码
A06AB58 sodium picosulfate, combinations
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Product Information
|
r_labellingsubmissiondocument_2201370_clean
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase